Linden Capital L.P. 13D and 13G filings for Revelation Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-31 3:31 pm Sale | 2022-12-31 | 13G | Revelation Biosciences, Inc. REVB | Linden Capital L.P. | 43 3.000% | -5 (-10.01%) | Filing |
| 2022-01-19 7:14 pm Purchase | 2022-01-14 | 13G | Revelation Biosciences, Inc. REVB | Linden Capital L.P. | 47 5.800% | 47 (New Position) | Filing |